Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nagy

Showing results (251-260 of 395) with videos related to

Pageof 40
Sort By:
Physiology International|July 6, 2018
Arterial stiffness may predict renal and cardiovascular prognosis in autosomal-dominant polycystic kidney diseaseB Sági, I Késői, B Késői, et al.
European Journal of Neurology|October 10, 2019
Positive response to galcanezumab following treatment failure to onabotulinumtoxinA in patients with migraine: post hoc analyses of three randomized double-blind studiesJ Ailani, E Pearlman, Q Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1993
Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdosesP J Boyle, K Justice, A J Krentz, et al.
Acta Morphologica Hungarica|January 1, 1984
IgA glomerulonephritis: light microscopic and immunohistological studiesJ Nagy, H Brasch, G Deák, et al.
Orvosi Hetilap|February 22, 1970
[Conduction disorders associated with myocardial infarction]F Solti, A Hartai, M Iskum, et al.
Acta Medica Academiae Scientiarum Hungaricae|January 1, 1970
[Regulation of the blood supply of the limbs in lymphedema of the limbs]F Solti, J Nagy, J Gergely, et al.
Orvosi Hetilap|January 1, 1989
[Antibodies against nutritional antigens in IgA nephropathy]J Nagy, H Scott, P Brandtzaeg, et al.
Orvosi Hetilap|July 16, 1989
[IgA and IgG antibodies to Chlamydia in IgA nephropathy as well as in mesangiocapillary and membranous glomerulonephritis]J Nagy, I Sarov, J Sámik, et al.
Orvosi Hetilap|May 2, 1982
[Circulating immunocomplexes and cryoprecipitates in IgA glomerulonephritis]J Nagy, G Füst, M Ambrus, et al.
Frontiers in Oncology|September 14, 2018
Cell-Free DNA Profiling to Discover Mechanisms of Exceptional Response to Cabozantinib Plus Panitumumab in a Patient With Treatment Refractory Metastatic Colorectal CancerJingquan Jia, Michael A Morse, Rebecca J Nagy, et al.
Pageof 40

Showing results (251-260 of 395) with videos related to

Sort By:
Pageof 40
Physiology International|July 6, 2018
Arterial stiffness may predict renal and cardiovascular prognosis in autosomal-dominant polycystic kidney diseaseB Sági, I Késői, B Késői, et al.
European Journal of Neurology|October 10, 2019
Positive response to galcanezumab following treatment failure to onabotulinumtoxinA in patients with migraine: post hoc analyses of three randomized double-blind studiesJ Ailani, E Pearlman, Q Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1993
Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdosesP J Boyle, K Justice, A J Krentz, et al.
Acta Morphologica Hungarica|January 1, 1984
IgA glomerulonephritis: light microscopic and immunohistological studiesJ Nagy, H Brasch, G Deák, et al.
Orvosi Hetilap|February 22, 1970
[Conduction disorders associated with myocardial infarction]F Solti, A Hartai, M Iskum, et al.
Acta Medica Academiae Scientiarum Hungaricae|January 1, 1970
[Regulation of the blood supply of the limbs in lymphedema of the limbs]F Solti, J Nagy, J Gergely, et al.
Orvosi Hetilap|January 1, 1989
[Antibodies against nutritional antigens in IgA nephropathy]J Nagy, H Scott, P Brandtzaeg, et al.
Orvosi Hetilap|July 16, 1989
[IgA and IgG antibodies to Chlamydia in IgA nephropathy as well as in mesangiocapillary and membranous glomerulonephritis]J Nagy, I Sarov, J Sámik, et al.
Orvosi Hetilap|May 2, 1982
[Circulating immunocomplexes and cryoprecipitates in IgA glomerulonephritis]J Nagy, G Füst, M Ambrus, et al.
Frontiers in Oncology|September 14, 2018
Cell-Free DNA Profiling to Discover Mechanisms of Exceptional Response to Cabozantinib Plus Panitumumab in a Patient With Treatment Refractory Metastatic Colorectal CancerJingquan Jia, Michael A Morse, Rebecca J Nagy, et al.
Pageof 40